Combined Cis-Platinum and Radiation Therapy in Patients with Stages PT3 and PT4 Bladder Cancer: A Pilot Study
- 1 March 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 129 (3) , 501-504
- https://doi.org/10.1016/s0022-5347(17)52202-8
Abstract
A prospective study was done on 8 patients with advanced transitional cell carcinoma of the bladder to evaluate toxicity of an integrated treatment with cis-diamminedichloroplatinum (1.6 mg/kg body wt 3 times/wk) and 60 gray 60Co or 18 MeV photons. Local and systemic toxicity caused by this treatment schedule was minor. Late sequelae consisted of a contracted bladder in 1 patient. The rate of bladders free of tumor after a mean follow-up of 7.7 mo. was surprisingly high (6 of 8).This publication has 12 references indexed in Scilit:
- Radiation therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Combination radiotherapy and chemotherapy in murine bladder cancerUrology, 1979
- Cis-diamminedichloroplatinum II in Advanced Urothelial CancerJournal of Urology, 1978
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- Single-Drug Chemotherapy of Bladder Cancer with Adriamycin, VM-26 or BleomycinEuropean Urology, 1976
- Bladder Cancer: Results of Radiation Therapy in 384 PatientsRadiology, 1975
- Single and combination chemotherapy for primary murine bladder cancerCancer, 1975
- The continuous arterial infusion of 5-fluorouracil as a therapeutic adjunct in the treatment of advanced carcinoma of the bladder and prostate.A preliminary reportCancer, 1973
- The treatment of carcinoma of the bladder by external irradiation a clinical trial—Part IIClinical Radiology, 1971
- Malignant Disease of the Urinary BladderAustralasian Radiology, 1969